BRIEF-Terns Announces Proposed Public Offering

Reuters12-09

Dec 9 (Reuters) - Terns Pharmaceuticals Inc TERN.O:

TERNS ANNOUNCES PROPOSED PUBLIC OFFERING
TERNS PHARMACEUTICALS INC - ANNOUNCES $400 MILLION PUBLIC OFFERING
TERNS PHARMACEUTICALS INC - GRANTS OPTION FOR ADDITIONAL $60 MILLION SHARES
TERNS PHARMACEUTICALS INC - TO USE PROCEEDS FOR RESEARCH AND TERN-701 DEVELOPMENT

Source text: ID:nGNX7MKJR6

Further company coverage: TERN.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590348394?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-09 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590348394","market":"us","top_or_hot":-1,"title":"BRIEF-Terns Announces Proposed Public Offering","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Terns Announces Proposed Public Offering</title></head><body><p><span>Dec 9 (Reuters)</span><span> - </span>Terns Pharmaceuticals Inc <span>TERN.O</span>:</p><ul><li><p>TERNS ANNOUNCES PROPOSED PUBLIC OFFERING</p></li><li><p>TERNS PHARMACEUTICALS INC - ANNOUNCES $400 MILLION PUBLIC OFFERING</p></li><li><p>TERNS PHARMACEUTICALS INC - GRANTS OPTION FOR ADDITIONAL $60 MILLION SHARES</p></li><li><p>TERNS PHARMACEUTICALS INC - TO USE PROCEEDS FOR RESEARCH AND TERN-701 DEVELOPMENT</p></li></ul><p>Source text: <span>ID:nGNX7MKJR6</span></p><p>Further company coverage: <span>TERN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Terns Announces Proposed Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Terns Announces Proposed Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-09 19:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Terns Announces Proposed Public Offering</title></head><body><p><span>Dec 9 (Reuters)</span><span> - </span>Terns Pharmaceuticals Inc <span>TERN.O</span>:</p><ul><li><p>TERNS ANNOUNCES PROPOSED PUBLIC OFFERING</p></li><li><p>TERNS PHARMACEUTICALS INC - ANNOUNCES $400 MILLION PUBLIC OFFERING</p></li><li><p>TERNS PHARMACEUTICALS INC - GRANTS OPTION FOR ADDITIONAL $60 MILLION SHARES</p></li><li><p>TERNS PHARMACEUTICALS INC - TO USE PROCEEDS FOR RESEARCH AND TERN-701 DEVELOPMENT</p></li></ul><p>Source text: <span>ID:nGNX7MKJR6</span></p><p>Further company coverage: <span>TERN.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TERN","symbol_name":"Terns Pharmaceuticals, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUA9RQVNV:1","article_id":"2590348394","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590348394","pubTimestamp":1765279417,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Terns Announces Proposed Public OfferingDec 9 (Reuters) - Terns Pharmaceuticals Inc TERN.O:TERNS ANNOUNCES PROPOSED PUBLIC OFFERINGTERNS PHARMACEUTICALS INC - ANNOUNCES $400 MILLION PUBLIC OFFER","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TERN":"Terns Pharmaceuticals, Inc.","BK4007":"制药"},"translate_title":"BRIEF-Terns宣布拟议公开发行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TERN":0.9},"content_text":"BRIEF-Terns Announces Proposed Public OfferingDec 9 (Reuters) - Terns Pharmaceuticals Inc TERN.O:TERNS ANNOUNCES PROPOSED PUBLIC OFFERINGTERNS PHARMACEUTICALS INC - ANNOUNCES $400 MILLION PUBLIC OFFERINGTERNS PHARMACEUTICALS INC - GRANTS OPTION FOR ADDITIONAL $60 MILLION SHARESTERNS PHARMACEUTICALS INC - TO USE PROCEEDS FOR RESEARCH AND TERN-701 DEVELOPMENTSource text: ID:nGNX7MKJR6Further company coverage: TERN.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590348394","isCrawlerRequest":true}